AVITA MEDICAL INC. - Announcements

0.38%

$1.30

Market Cap $95.74M

Healthcare Biotechnology

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies... AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

AVH	POSITIVE RECELL INTERIM CLINICAL STUDY RESULTS	PRICE SENSITIVE	18/10/13	136.63KB	Share
AVH	Full Year Statutory Accounts		30/09/13	851.19KB	Share
AVH	Preliminary Final Report	PRICE SENSITIVE	30/08/13	200.78KB	Share
AVH	Completion of Enrollment for ReCell Vitiligo Trial	PRICE SENSITIVE	21/08/13	146.11KB	Share
AVH	Enrolment of Patients in Recell Chronic Leg Ulcer Trial	PRICE SENSITIVE	01/08/13	346.62KB	Share
AVH	Quarterly Report June 2013	PRICE SENSITIVE	30/07/13	132.48KB	Share
AVH	Appendix 3B		28/06/13	70.1KB	Share
AVH	AVH Analyst Coverage		19/06/13	117.43KB	Share
AVH	Change in substantial holding		06/06/13	66.6KB	Share
AVH	Becoming a substantial holder		06/06/13	65.34KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/13	121.4KB	Share
AVH	Japanese Patent Granted - Expands Commercial Rights	PRICE SENSITIVE	10/04/13	135.97KB	Share
AVH	ReCell Sypmosium with Leading EU Surgeons		28/03/13	451.36KB	Share
AVH	Cleansing Notice and Appendix 3B		20/03/13	74.41KB	Share
AVH	Appendix 3B plus Change of Director's Interests		06/03/13	197.18KB	Share
AVH	Half Year Report and Accounts	PRICE SENSITIVE	27/02/13	266.22KB	Share
AVH	Avita Medical Investor and Shareholder Update		27/02/13	672.84KB	Share
AVH	AVH Completes CE Mark Recertification and ISO Audit	PRICE SENSITIVE	13/02/13	334.99KB	Share
AVH	APPOINTS DR MICHAEL PERRY TO BOARD		06/02/13	124.69KB	Share
AVH	Quarterly Cash Flow Q2 FY13	PRICE SENSITIVE	29/01/13	187.88KB	Share
AVH	CEO 2012 AGM Presentation		29/11/12	2.16MB	Share
AVH	Results of AGM		29/11/12	74.52KB	Share
AVH	Shareholder Update		28/11/12	345.18KB	Share
AVH	Chronic Wound Research underway within key EU Markets	PRICE SENSITIVE	20/11/12	133.95KB	Share
AVH	Change in substantial holding		12/11/12	59.66KB	Share
AVH	Change in substantial holding		12/11/12	59.85KB	Share
AVH	Change of Director's Interest Notice		05/11/12	71.02KB	Share
AVH	Avita Presents SoCalBio Investor Conference		05/11/12	99.41KB	Share
AVH	Completion of Placement and Cleansing Statement		31/10/12	75.55KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/12	119.9KB	Share
AVH	Notice of Annual General Meeting/Proxy Form		26/10/12	547.31KB	Share
AVH	Appendix 3B		22/10/12	68.67KB	Share
AVH	Change of Director's Interest Notice		22/10/12	54.3KB	Share
AVH	Final Director's Interest Notice		19/10/12	11.66KB	Share
AVH	Results of Meeting		19/10/12	124.66KB	Share
AVH	Avita Strengthens Board / Appendix 3X x 2		19/10/12	127.85KB	Share
AVH	Annual Report to shareholders		17/10/12	946.16KB	Share
AVH	Completes Share Purchase Plan with total Capital raised $10m		16/10/12	179.07KB	Share
AVH	Share Purchase Plan Extension		02/10/12	116.5KB	Share
AVH	Full Year Statutory Accounts		01/10/12	896.12KB	Share
AVH	Avita secures additional funding from US Dept of Defence	PRICE SENSITIVE	28/09/12	255KB	Share
AVH	Notice of General Meeting/Proxy Form		17/09/12	493.21KB	Share
AVH	Change in substantial holding		17/09/12	100.79KB	Share
AVH	Avita Completes Tranche 1 Placement Cleansing Notice		12/09/12	100.61KB	Share
AVH	ReCell Presentation International Society for Burns Injuries		11/09/12	130.06KB	Share
AVH	Cleansing Statement Share Purchase Plan		06/09/12	19.59KB	Share
AVH	Share Purchase Plan Offer		06/09/12	337.26KB	Share
AVH	Capital Raising	PRICE SENSITIVE	05/09/12	100.08KB	Share
AVH	Trading Halt	PRICE SENSITIVE	03/09/12	18.83KB	Share
AVH	Preliminary Final Report	PRICE SENSITIVE	31/08/12	198.39KB	Share
AVH	Avita Announces Manufacturing Advances	PRICE SENSITIVE	27/08/12	138.31KB	Share
AVH +WIG	Ceasing to be a substantial holder from WIG		06/08/12	158.03KB	Share
AVH	Appendix 3B Amended		06/08/12	69.8KB	Share
AVH	Appendix 3B		06/08/12	76.71KB	Share
AVH	June Quarterly Report FY12	PRICE SENSITIVE	31/07/12	115.27KB	Share
AVH	Shareholder Update	PRICE SENSITIVE	30/07/12	2.5MB	Share
AVH	China Distributor Appointed		07/06/12	112.57KB	Share
AVH	AVMXF Shares to AVMXY ADRS Update		05/06/12	100.61KB	Share
AVH	Appendix 3B		29/05/12	97KB	Share
AVH	CEO Investor Presentation		23/05/12	4.64MB	Share
AVH	CEO Investor Conference		17/05/12	238.44KB	Share
AVH	FDA Study for Cosmetic Indications	PRICE SENSITIVE	10/05/12	138.68KB	Share
AVH	Quarterly Report	PRICE SENSITIVE	27/04/12	124.93KB	Share
AVH	Change in substantial holding - Correction		20/04/12	97.38KB	Share
AVH	Change in substantial holding		20/04/12	96.85KB	Share
AVH	Avita granted EU Patent	PRICE SENSITIVE	05/04/12	102.96KB	Share
AVH	AVH Sponsors Skin Regeneration Symposium		30/03/12	116.46KB	Share
AVH	INITIATES TRADING ON USA OTCQX		29/03/12	26.76KB	Share
AVH	Change in substantial holding		20/03/12	67.34KB	Share
AVH	AVH Commences Trading on US OTCQX ADR Market		09/03/12	109.15KB	Share
AVH	Bank of New York Mellon appointed for US OTC Listing		20/02/12	131.49KB	Share
AVH	Successfully completes ISO Quality Recertification	PRICE SENSITIVE	09/02/12	104.7KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/12	114.75KB	Share
AVH	Change in substantial holding		19/12/11	66.17KB	Share
AVH +WIG	Change in substantial holding from WIG		06/12/11	185.39KB	Share
AVH	ReCell Expansion of Sales into Italy	PRICE SENSITIVE	01/12/11	185.84KB	Share
AVH	IP Transfer Completed	PRICE SENSITIVE	29/11/11	186.44KB	Share
AVH	CEO Dr Dolphin Contract Extension		24/11/11	158.89KB	Share
AVH	Popular Science Best of Award		24/11/11	180.26KB	Share
AVH	Results of Annual General Meeting		18/11/11	67.31KB	Share
AVH	CEO AGM Presentation		18/11/11	14.2MB	Share
AVH	Change in substantial holding		03/11/11	65.54KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/11	121.89KB	Share
AVH	Annual Report to shareholders		25/10/11	1.87MB	Share
AVH	Notice of Annual General Meeting/Proxy Form		17/10/11	619.17KB	Share
AVH	Launches ReCell for Treatment of Chronic Ulcers	PRICE SENSITIVE	13/10/11	196.74KB	Share
AVH +WIG	Change in substantial holding from WIG		06/10/11	178.75KB	Share
AVH	Appendix 3B and Appendix 3Y - cancellation of Options		05/10/11	76.88KB	Share
AVH	Full Year Statutory Accounts		30/09/11	552.63KB	Share
AVH	Investor and Shareholder Update		19/09/11	460.48KB	Share
AVH	ReCell JV Middle East and North Africa Launch	PRICE SENSITIVE	07/09/11	173.51KB	Share
AVH	Preliminary Final Report	PRICE SENSITIVE	31/08/11	220.23KB	Share
AVH	Appoints Senior Researcher to Expand Regenerative R and D		26/08/11	134.51KB	Share
AVH	FDA ReCell Approval Received for Study Cosmetic Indications	PRICE SENSITIVE	25/08/11	151.9KB	Share
AVH	Record 4th Quarter ReCell and Year End Financial Performance		02/08/11	123.13KB	Share
AVH	Change in substantial holding		02/08/11	108.17KB	Share
AVH	Analyst Coverage Wilson HTM		01/08/11	133.2KB	Share
AVH	Appendix 4C - quarterly	PRICE SENSITIVE	01/08/11	147.6KB	Share
AVH	Change in substantial holding		12/07/11	106.51KB	Share
AVH	Change in substantial holding		12/07/11	99.55KB	Share

AVHPOSITIVE RECELL INTERIM CLINICAL STUDY RESULTS
18/10/13	PRICE SENSITIVE	136.63KB	Share
AVHFull Year Statutory Accounts
30/09/13		851.19KB	Share
AVHPreliminary Final Report
30/08/13	PRICE SENSITIVE	200.78KB	Share
AVHCompletion of Enrollment for ReCell Vitiligo Trial
21/08/13	PRICE SENSITIVE	146.11KB	Share
AVHEnrolment of Patients in Recell Chronic Leg Ulcer Trial
01/08/13	PRICE SENSITIVE	346.62KB	Share
AVHQuarterly Report June 2013
30/07/13	PRICE SENSITIVE	132.48KB	Share
AVHAppendix 3B
28/06/13		70.1KB	Share
AVHAVH Analyst Coverage
19/06/13		117.43KB	Share
AVHChange in substantial holding
06/06/13		66.6KB	Share
AVHBecoming a substantial holder
06/06/13		65.34KB	Share
AVHAppendix 4C - quarterly
29/04/13	PRICE SENSITIVE	121.4KB	Share
AVHJapanese Patent Granted - Expands Commercial Rights
10/04/13	PRICE SENSITIVE	135.97KB	Share
AVHReCell Sypmosium with Leading EU Surgeons
28/03/13		451.36KB	Share
AVHCleansing Notice and Appendix 3B
20/03/13		74.41KB	Share
AVHAppendix 3B plus Change of Director's Interests
06/03/13		197.18KB	Share
AVHHalf Year Report and Accounts
27/02/13	PRICE SENSITIVE	266.22KB	Share
AVHAvita Medical Investor and Shareholder Update
27/02/13		672.84KB	Share
AVHAVH Completes CE Mark Recertification and ISO Audit
13/02/13	PRICE SENSITIVE	334.99KB	Share
AVHAPPOINTS DR MICHAEL PERRY TO BOARD
06/02/13		124.69KB	Share
AVHQuarterly Cash Flow Q2 FY13
29/01/13	PRICE SENSITIVE	187.88KB	Share
AVHCEO 2012 AGM Presentation
29/11/12		2.16MB	Share
AVHResults of AGM
29/11/12		74.52KB	Share
AVHShareholder Update
28/11/12		345.18KB	Share
AVHChronic Wound Research underway within key EU Markets
20/11/12	PRICE SENSITIVE	133.95KB	Share
AVHChange in substantial holding
12/11/12		59.66KB	Share
AVHChange in substantial holding
12/11/12		59.85KB	Share
AVHChange of Director's Interest Notice
05/11/12		71.02KB	Share
AVHAvita Presents SoCalBio Investor Conference
05/11/12		99.41KB	Share
AVHCompletion of Placement and Cleansing Statement
31/10/12		75.55KB	Share
AVHAppendix 4C - quarterly
31/10/12	PRICE SENSITIVE	119.9KB	Share
AVHNotice of Annual General Meeting/Proxy Form
26/10/12		547.31KB	Share
AVHAppendix 3B
22/10/12		68.67KB	Share
AVHChange of Director's Interest Notice
22/10/12		54.3KB	Share
AVHFinal Director's Interest Notice
19/10/12		11.66KB	Share
AVHResults of Meeting
19/10/12		124.66KB	Share
AVHAvita Strengthens Board / Appendix 3X x 2
19/10/12		127.85KB	Share
AVHAnnual Report to shareholders
17/10/12		946.16KB	Share
AVHCompletes Share Purchase Plan with total Capital raised $10m
16/10/12		179.07KB	Share
AVHShare Purchase Plan Extension
02/10/12		116.5KB	Share
AVHFull Year Statutory Accounts
01/10/12		896.12KB	Share
AVHAvita secures additional funding from US Dept of Defence
28/09/12	PRICE SENSITIVE	255KB	Share
AVHNotice of General Meeting/Proxy Form
17/09/12		493.21KB	Share
AVHChange in substantial holding
17/09/12		100.79KB	Share
AVHAvita Completes Tranche 1 Placement Cleansing Notice
12/09/12		100.61KB	Share
AVHReCell Presentation International Society for Burns Injuries
11/09/12		130.06KB	Share
AVHCleansing Statement Share Purchase Plan
06/09/12		19.59KB	Share
AVHShare Purchase Plan Offer
06/09/12		337.26KB	Share
AVHCapital Raising
05/09/12	PRICE SENSITIVE	100.08KB	Share
AVHTrading Halt
03/09/12	PRICE SENSITIVE	18.83KB	Share
AVHPreliminary Final Report
31/08/12	PRICE SENSITIVE	198.39KB	Share
AVHAvita Announces Manufacturing Advances
27/08/12	PRICE SENSITIVE	138.31KB	Share
AVH +WIGCeasing to be a substantial holder from WIG
06/08/12		158.03KB	Share
AVHAppendix 3B Amended
06/08/12		69.8KB	Share
AVHAppendix 3B
06/08/12		76.71KB	Share
AVHJune Quarterly Report FY12
31/07/12	PRICE SENSITIVE	115.27KB	Share
AVHShareholder Update
30/07/12	PRICE SENSITIVE	2.5MB	Share
AVHChina Distributor Appointed
07/06/12		112.57KB	Share
AVHAVMXF Shares to AVMXY ADRS Update
05/06/12		100.61KB	Share
AVHAppendix 3B
29/05/12		97KB	Share
AVHCEO Investor Presentation
23/05/12		4.64MB	Share
AVHCEO Investor Conference
17/05/12		238.44KB	Share
AVHFDA Study for Cosmetic Indications
10/05/12	PRICE SENSITIVE	138.68KB	Share
AVHQuarterly Report
27/04/12	PRICE SENSITIVE	124.93KB	Share
AVHChange in substantial holding - Correction
20/04/12		97.38KB	Share
AVHChange in substantial holding
20/04/12		96.85KB	Share
AVHAvita granted EU Patent
05/04/12	PRICE SENSITIVE	102.96KB	Share
AVHAVH Sponsors Skin Regeneration Symposium
30/03/12		116.46KB	Share
AVHINITIATES TRADING ON USA OTCQX
29/03/12		26.76KB	Share
AVHChange in substantial holding
20/03/12		67.34KB	Share
AVHAVH Commences Trading on US OTCQX ADR Market
09/03/12		109.15KB	Share
AVHBank of New York Mellon appointed for US OTC Listing
20/02/12		131.49KB	Share
AVHSuccessfully completes ISO Quality Recertification
09/02/12	PRICE SENSITIVE	104.7KB	Share
AVHAppendix 4C - quarterly
31/01/12	PRICE SENSITIVE	114.75KB	Share
AVHChange in substantial holding
19/12/11		66.17KB	Share
AVH +WIGChange in substantial holding from WIG
06/12/11		185.39KB	Share
AVHReCell Expansion of Sales into Italy
01/12/11	PRICE SENSITIVE	185.84KB	Share
AVHIP Transfer Completed
29/11/11	PRICE SENSITIVE	186.44KB	Share
AVHCEO Dr Dolphin Contract Extension
24/11/11		158.89KB	Share
AVHPopular Science Best of Award
24/11/11		180.26KB	Share
AVHResults of Annual General Meeting
18/11/11		67.31KB	Share
AVHCEO AGM Presentation
18/11/11		14.2MB	Share
AVHChange in substantial holding
03/11/11		65.54KB	Share
AVHAppendix 4C - quarterly
28/10/11	PRICE SENSITIVE	121.89KB	Share
AVHAnnual Report to shareholders
25/10/11		1.87MB	Share
AVHNotice of Annual General Meeting/Proxy Form
17/10/11		619.17KB	Share
AVHLaunches ReCell for Treatment of Chronic Ulcers
13/10/11	PRICE SENSITIVE	196.74KB	Share
AVH +WIGChange in substantial holding from WIG
06/10/11		178.75KB	Share
AVHAppendix 3B and Appendix 3Y - cancellation of Options
05/10/11		76.88KB	Share
AVHFull Year Statutory Accounts
30/09/11		552.63KB	Share
AVHInvestor and Shareholder Update
19/09/11		460.48KB	Share
AVHReCell JV Middle East and North Africa Launch
07/09/11	PRICE SENSITIVE	173.51KB	Share
AVHPreliminary Final Report
31/08/11	PRICE SENSITIVE	220.23KB	Share
AVHAppoints Senior Researcher to Expand Regenerative R and D
26/08/11		134.51KB	Share
AVHFDA ReCell Approval Received for Study Cosmetic Indications
25/08/11	PRICE SENSITIVE	151.9KB	Share
AVHRecord 4th Quarter ReCell and Year End Financial Performance
02/08/11		123.13KB	Share
AVHChange in substantial holding
02/08/11		108.17KB	Share
AVHAnalyst Coverage Wilson HTM
01/08/11		133.2KB	Share
AVHAppendix 4C - quarterly
01/08/11	PRICE SENSITIVE	147.6KB	Share
AVHChange in substantial holding
12/07/11		106.51KB	Share
AVHChange in substantial holding
12/07/11		99.55KB	Share

REFRESH

First 10 11 12 13 14

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.30		Change -0.005(0.38%)		Mkt cap ! $95.74M

Open	High	Low	Value	Volume
$1.31	$1.31	$1.29	$262.1K	201.6K

Buyers (Bids)

No.	Vol.	Price($)
4	23015	$1.30

Sellers (Offers)

Price($)	Vol.	No.
$1.30	7216	7

View Market Depth

No.	Vol.	Price($)
4	23015	1.295
8	37589	1.290
5	10928	1.285
10	35217	1.280
3	12000	1.275

Price($)	Vol.	No.
1.300	7216	7
1.305	16270	4
1.310	25815	3
1.315	2617	2
1.320	7041	2

Last trade - 13.15pm 10/09/2025 (20 minute delay)


Last $1.30		Change -0.005 ( 0.38 %)
Open	High	Low	Volume
$1.30	$1.31	$1.30	20570
Last updated 14.11pm 10/09/2025 ?

AVH (ASX) Chart

AVITA MEDICAL INC. - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories